Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs.
about
Potential Targets for Antifungal Drug Discovery Based on Growth and Virulence in Candida albicansComponents of the calcium-calcineurin signaling pathway in fungal cells and their potential as antifungal targetsSynergistic combinations of antifungals and anti-virulence agents to fight against Candida albicansAn automated high-throughput cell-based multiplexed flow cytometry assay to identify novel compounds to target Candida albicans virulence-related proteinsSynergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicansCandida albicans Niche Specialization: Features That Distinguish Biofilm Cells from Commensal Cells.Overcoming antifungal resistance.In vitro analysis of finasteride activity against Candida albicans urinary biofilm formation and filamentation.In vitro and in vivo antifungal activities of selected Cameroonian dietary spicesHigh-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation.Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis.In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model.A Novel Small Molecule Inhibitor of Candida albicans Biofilm Formation, Filamentation and Virulence with Low Potential for the Development of Resistance.Distinct stages during colonization of the mouse gastrointestinal tract by Candida albicansPhotodynamic therapy of oral Candida infection in a mouse model.Screening the Pathogen Box for Identification of Candida albicans Biofilm InhibitorsEffect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study.From Biology to Drug Development: New Approaches to Combat the Threat of Fungal BiofilmsA complex game of hide and seek: the search for new antifungalsProteomics progresses in microbial physiology and clinical antimicrobial therapy.Adaptation of Candida albicans to commensalism in the gut.Transcriptional Profiling of Biofilm Regulators Identified by an Overexpression Screen in Saccharomyces cerevisiae.A novel in vitro assay for assessing efficacy and toxicity of antifungals using human leukaemic cells infected with Candida albicans.Synergism Effect of the Essential Oil from Ocimum basilicum var. Maria Bonita and Its Major Components with Fluconazole and Its Influence on Ergosterol Biosynthesis.A New Series of Pyrrole-Based Chalcones: Synthesis and Evaluation of Antimicrobial Activity, Cytotoxicity, and Genotoxicity.Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation.Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds.The two transmembrane regions of Candida albicans Dfi1 contribute to its biogenesis.Functional analysis of selected deletion mutants in Candida glabrata under hypoxia.Synergistic antifungal effect of chitosan-stabilized selenium nanoparticles synthesized by pulsed laser ablation in liquids against Candida albicans biofilms.MALDI-TOF MS Applications to the Detection of Antifungal Resistance: State of the Art and Future PerspectivesSynthesis andIn VitroEvaluation of New Thiosemicarbazone Derivatives as Potential Antimicrobial Agents
P2860
Q26801524-B5B1910D-5E64-43A5-B5D8-524D62A973DDQ28080558-D055CE54-8829-42F4-A5E4-6206BE695F54Q28082407-4E49D0C2-CCD4-44D2-A55F-EE2EE6B46B5FQ28544418-132A4BCC-E38E-41E5-94CF-9B9AA280A9DEQ28550850-742787A4-67C2-4FDF-9CC1-2C9EF8C17135Q33603993-4C35A4C4-E2BC-4E19-ADF7-1C4958EDF4FCQ33651853-911F2B03-6AA8-4E1E-9969-F3DF4341B004Q34298898-31F2CA22-B62A-414A-B69C-8744D9968561Q35095865-B54683F8-9D5A-4FFE-A322-51A68EFB9A51Q35119312-DF079681-67D3-40F5-9E41-86D75459D7CFQ35187151-0BC88B15-CB7A-44F1-BADC-F30FAC950CD2Q35433089-C2750E2B-1043-42AA-B362-1AA9556CBDF5Q35874892-4EA42C78-AA32-4C1B-8390-8713EAC32908Q35918461-725EFF9C-FD2A-438E-B391-9AC8B61A190EQ35988608-8B3B761D-71E1-4FBF-8E2B-392336B138E4Q36177985-7D9FE504-7E44-4F8C-8A98-97A55EAAA7BFQ36370400-1F812EBD-48D4-44DE-AD3D-64D46F6990F0Q36422270-49DD5D90-1906-4B13-9C61-CBE4BCB08759Q37344546-265E11FC-FC93-439C-A473-CC7F790D839FQ37642133-BE72C599-40F5-4B38-BF01-7429490F4015Q38806236-CB2FC76B-89AA-4330-A26C-C03783163A00Q40148587-7853F12A-C6D9-4B1B-AF6D-2D397B23A4A8Q41353429-A54C8947-DEEB-4B52-8671-5648EA44FE50Q42778525-09509259-4F37-4D26-A386-3BA376A89299Q46251280-BA2B003F-8DF9-40D8-AEEB-88A980ECED0FQ47189974-66590B47-26CC-47BC-95A8-11D0227D4AEBQ48163141-FDDDCCCF-05FE-4517-9BA3-5EEF57628097Q51014343-2CB4D7F6-9FCC-4C12-91BC-9B5A12E05A1EQ53734576-E85A1343-91DD-4B11-8979-827AE8041D70Q55096310-0FE2DBDB-EB54-4FB7-A6F6-EE3725DD565BQ58693906-33E4EE9C-1DFE-465B-8BC9-E719DEC9C50BQ59125416-314B1020-AFA6-4964-87AC-5C05330BAC7D
P2860
Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Candidiasis drug discovery and ...... ing and identifying new drugs.
@en
Candidiasis drug discovery and ...... ing and identifying new drugs.
@nl
type
label
Candidiasis drug discovery and ...... ing and identifying new drugs.
@en
Candidiasis drug discovery and ...... ing and identifying new drugs.
@nl
prefLabel
Candidiasis drug discovery and ...... ing and identifying new drugs.
@en
Candidiasis drug discovery and ...... ing and identifying new drugs.
@nl
P2860
P1476
Candidiasis drug discovery and ...... ing and identifying new drugs.
@en
P2093
Christopher G Pierce
Jose L Lopez-Ribot
P2860
P304
P356
10.1517/17460441.2013.807245
P407
P577
2013-06-06T00:00:00Z